Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 20.05 CNY -1.96%
Market Cap: 22.4B CNY
Have any thoughts about
Shenzhen Kangtai Biological Products Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shenzhen Kangtai Biological Products Co Ltd

Wall Street analysts forecast Shenzhen Kangtai Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 20.63 CNY with a low forecast of 10.92 CNY and a high forecast of 35.37 CNY.

Lowest
Price Target
10.92 CNY
46% Downside
Average
Price Target
20.63 CNY
3% Upside
Highest
Price Target
35.37 CNY
76% Upside
Shenzhen Kangtai Biological Products Co Ltd Competitors:
Price Targets
KOD
Kodiak Sciences Inc
49% Downside
SVE
Synthaverse SA
52% Upside
ALEC
Alector Inc
174% Upside
IOVA
Iovance Biotherapeutics Inc
178% Upside
BONEX
Bonesupport Holding AB
5% Downside
CRVO
Diffusion Pharmaceuticals Inc
424% Upside
GMAB
Genmab A/S
70% Upside
MDXG
MiMedx Group Inc
67% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 10%.

29%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 38%. The projected CAGR for the next 3 years is 14%.

38%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 39%. The projected CAGR for the next 3 years is 0%.

39%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Kangtai Biological Products Co Ltd's stock price target?
Price Target
20.63 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 20.63 CNY with a low forecast of 10.92 CNY and a high forecast of 35.37 CNY.

What is Shenzhen Kangtai Biological Products Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 10%.

What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 38%. The projected CAGR for the next 3 years is 14%.

What is Shenzhen Kangtai Biological Products Co Ltd's Net Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 39%. The projected CAGR for the next 3 years is 0%.

Back to Top